Free Trial

Veradigm (NASDAQ:MDRX) Shares Gap Down - Should You Sell?

Veradigm logo with Business Services background

Key Points

  • Veradigm Inc. (NASDAQ:MDRX) saw its share price gap down from a previous close of $4.83 to an opening price of $4.60, last trading at $4.65 with a volume of 2,192 shares.
  • Wall Street analysts have given Veradigm a "hold" rating, as coverage was initiated by Wall Street Zen.
  • The company's 50-day moving average is $4.53, while the 200-day moving average is $5.12, showing a downward trend.
  • Veradigm is a healthcare technology company providing IT solutions and services including electronic health records, analytics, and population health management.
  • Need better tools to track Veradigm? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Veradigm Inc. (NASDAQ:MDRX - Get Free Report)'s share price gapped down before the market opened on Friday . The stock had previously closed at $4.83, but opened at $4.60. Veradigm shares last traded at $4.65, with a volume of 2,192 shares.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen started coverage on shares of Veradigm in a research report on Tuesday, May 20th. They set a "hold" rating for the company.

Check Out Our Latest Report on Veradigm

Veradigm Price Performance

The stock's 50-day moving average is $4.55 and its 200-day moving average is $4.99.

Veradigm Company Profile

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Featured Stories

Should You Invest $1,000 in Veradigm Right Now?

Before you consider Veradigm, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.

While Veradigm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines